Am J Surg. 2013;206(1):40-6.
The optimal duration of preoperative biliary drainage for periampullary tumors that cause severe obstructive jaundice.
제1저자 손준혁/김재환 · 교신저자 이상협
소속 (1)
- Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Abstract
BACKGROUND Despite routine preoperative biliary drainage (PBD) with periampullary cancer, its optimal duration has not been established. The objective of this study was to investigate PBD in severely jaundiced patients.
METHODS A total of 120 patients with periampullary tumors who underwent surgery with intent to cure after PBD for severe obstructive jaundice were enrolled. According to the duration of PBD, 66 and 54 patients were classified into the long-term (≥2 weeks) and short-term (<2 weeks) groups.
RESULTS PBD-related complications occurred in 6 (9.1%) and 14 (25.9%) patients in the short-term and long-term groups, respectively (P = .014). Rates of surgery-related complications and mortalities were not significantly different between the 2 groups. The R0 resection rate tended to be lower (P = .054) and the mean length of hospital stay was significantly longer (P = .039) in the long-term group.
CONCLUSIONS PBD duration <2 weeks is more appropriate in severely jaundiced patients with periampullary cancer.
Copyright © 2013 Elsevier Inc. All rights reserved.
그 밖의 정보
- 출판 형태
- Journal Article
- 저널
- American journal of surgery · eISSN 1879-1883
- 전자 출판
- 2013-05-22
- MeSH
- Adult · Aged · Ampulla of Vater* · Biliary Tract Surgical Procedures* / adverse effects / methods · Bilirubin / blood · Cholangiography / methods · Cholangiopancreatography, Endoscopic Retrograde · Common Bile Duct Neoplasms / complications / surgery / therapy · Databases, Factual · Drainage* / adverse effects / methods / standards · Female · Humans · Jaundice, Obstructive / blood / etiology / therapy · Male · Middle Aged · Pancreaticojejunostomy · Preoperative Period* · Republic of Korea · Retrospective Studies · Time Factors · Treatment Outcome
- Substances
- Bilirubin